Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live News

Net profit of Procter & Gamble Health rose 25.56% to Rs 82.33 crore in the quarter ended September 2024 as against Rs 65.57 crore during the previous quarter ended September 2023. Sales rose 2.78% to Rs 313.41 crore in the quarter ended September 2024 as against Rs 304.93 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales313.41304.93 3 OPM %36.3929.08 - PBDT117.1794.53 24 PBT111.4088.05 27 NP82.3365.57 26 Powered by Capital Market - Live News

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 4 November 2024.Powered by Capital Market - Live News

Procter & Gamble Health announced that the 57th Annual General Meeting (AGM) of the company will be held on 5 December 2024.Powered by Capital Market - Live News

Net profit of Procter & Gamble Health declined 43.73% to Rs 16.78 crore in the quarter ended June 2024 as against Rs 29.82 crore during the previous quarter ended June 2023. Sales declined 5.74% to Rs 283.88 crore in the quarter ended June 2024 as against Rs 301.18 crore during the previous quarter ended June 2023.For the full year,net profit declined 12.42% to Rs 200.98 crore in the year ended June 2024 as against Rs 229.47 crore during the previous year ended June 2023. Sales declined 6.37% to Rs 1151.26 crore in the year ended June 2024 as against Rs 1229.62 crore during the previous year ended June 2023. ParticularsQuarter EndedYear EndedJun. 2024Jun. 2023% Var.Jun. 2024Jun. 2023% Var. Sales283.88301.18 -6 1151.261229.62 -6 OPM %17.0015.05 -26.5826.40 - PBDT50.1850.63 -1 320.91342.30 -6 PBT43.0244.13 -3 293.51314.20 -7 NP16.7829.82 -44 200.98229.47 -12 Powered by Capital Market - Live News